139. Mol Imaging Biol. 2018 Jun;20(3):436. doi: 10.1007/s11307-018-1189-8.Correction to: LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging ofTriple Negative Breast Cancer.Abulrob A(1)(2)(3), Corluka S(4), Blasiak B(5)(6), Gino Fallone B(7), PonjevicD(8), Matyas J(8), Tomanek B(9)(10)(11).Author information: (1)Department of Cellular and Molecular Medicine, Faculty of Medicine, Universityof Ottawa, Ottawa, ON, Canada. Abedelnasser.abulrob@nrc.gc.ca.(2)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada.Abedelnasser.abulrob@nrc.gc.ca.(3)Human Health Therapeutics Portfolio, National Research Council Canada, Ottawa,ON, K1A 0R6, Canada. Abedelnasser.abulrob@nrc.gc.ca.(4)Department of Cellular and Molecular Medicine, Faculty of Medicine, Universityof Ottawa, Ottawa, ON, Canada.(5)Institute of Nuclear Physics, Polish Academy of Sciences, Krakow, Poland.(6)Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.(7)Department of Oncology, University of Alberta, Edmonton, Canada.(8)Department of Comparative Biology & Experimental Medicine, Faculty ofVeterinary Medicine, University of Calgary, Calgary, Canada.(9)Institute of Nuclear Physics, Polish Academy of Sciences, Krakow, Poland.tomanek@ualberta.ca.(10)Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.tomanek@ualberta.ca.(11)Department of Oncology, University of Alberta, Edmonton, Canada.tomanek@ualberta.ca.Erratum for    Mol Imaging Biol. 2018 Jun;20(3):428-435.This article was updated to correct the spelling of B. Gino Fallone's name; it iscorrect as displayed above. Correction to: Mol Imaging Biol (2017). DOI:https://doi.org/10.1007/s11307-017-1140-4.DOI: 10.1007/s11307-018-1189-8 PMID: 29556946 